Evidence map›Paper›PMID 18791357›Full record

ArticleAnnals of surgery2008

Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Matthew P Brennan, Alan Dardik, Narutoshi Hibino, Jason D Roh, Gregory N Nelson, Xenophon Papademitris, Toshiharu Shinoka, Christopher K Breuer

Abstract read
In one paragraph

Article in Annals of surgery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 154 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Tissue Engineering of Vascular Grafts: A Case Report From Bench to Bedside and Back.Arteriosclerosis, thrombosis, and vascular biology · 2023
    Review
  8. Tissue engineering: Relevance to neonatal congenital heart disease.Seminars in fetal & neonatal medicine · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. The Role of Immunomodulation in Vein Graft Remodeling and Failure.Journal of cardiovascular translational research · 2021
    Review
  14. Cell-free vascular grafts that grow with the host.Advanced functional materials · 2020
    Article
  15. Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models.Animals : an open access journal from MDPI · 2020
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Matthew P BrennanDepartment of Surgery, Yale School of Medicine, New Haven, CT 06520, USA.
Alan Dardik
Narutoshi Hibino
Jason D Roh
Gregory N Nelson
Xenophon Papademitris
Toshiharu Shinoka
Christopher K Breuer
Yale University · US

Funding

Development of Second Generation Tissue Engineered Vascular GraftsK08HL083980 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2006 to 2010
$666k
Flow responses to carotid angioplastyK08HL079927 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2006 to 2009
$532k
NHLBI NIH HHS HL079927NHLBI NIH HHS HL83980NHLBI NIH HHS K08 HL079927NHLBI NIH HHS K08 HL083980
6 · The paper itself

Abstract

introductionThe development of a living, autologous vascular graft with the ability to grow holds great promise for advancing the field of pediatric cardiothoracic surgery.

objectiveTo evaluate the growth potential of a tissue-engineered vascular graft (TEVG) in a juvenile animal model.

methodsPolyglycolic acid nonwoven mesh tubes (3-cm length, 1.3-cm id; Concordia Fibers) coated with a 10% copolymer solution of 50:50 L-lactide and epsilon-caprolactone were statically seeded with 1 x 10 cells/cm autologous bone marrow derived mononuclear cells. Eight TEVGs (7 seeded, 1 unseeded control) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs. Subjects underwent bimonthly magnetic resonance angiography (Siemens 1.5 T) with vascular image analysis (www.BioimageSuite.org). One of 7-seeded grafts was explanted after 1 month and all others were explanted 6 months after implantation. Neotissue was characterized using qualitative histologic and immunohistochemical staining and quantitative biochemical analysis.

resultsAll grafts explanted at 6 months were patent and increased in volume as measured by difference in pixel summation in magnetic resonance angiography at 1 month and 6 months. The volume of seeded TEVGs at explant averaged 126.9% +/- 9.9% of their volume at 1 month. Magnetic resonance imaging demonstrated no evidence of aneurysmal dilation. TEVG resembled the native IVC histologically and had comparable collagen (157.9 +/- 26.4 microg/mg), elastin (186.9 +/- 16.7 microg/mg), and glycosaminoglycan (9.7 +/- 0.8 microg/mg) contents. Immunohistochemical staining and Western blot analysis showed that Ephrin-B4, a determinant of normal venous development, was acquired in the seeded grafts 6 months after implantation.

conclusionsTEVGs demonstrate evidence of growth and venous development when implanted in the IVC of a juvenile lamb model.

Indexed as

Biocompatible MaterialsBlood Vessel ProsthesisPolyglycolic AcidAnimalsBioprosthesisBone Marrow CellsModels, AnimalMonocytesProsthesis DesignSheepSurgical MeshTissue EngineeringVena Cava, InferiorBiocompatible MaterialsPolyglycolic Acid

Identifiers

PMID18791357
PMCPMC2726802
OpenAlexW2070213995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.